期刊文献+

肌细胞增强子2A基因突变对血管内皮细胞增殖的影响 被引量:2

Myocyte enhancer factor 2A gene regulate proliferation of endothelial cells
下载PDF
导出
摘要 目的探讨肌细胞增强子(MEF)2A基因突变对血管内皮细胞增殖的影响。方法采用人脐静脉内皮细胞,分别转染pcDNA3.0-GFP质粒(对照组)、野生型MEF2A质粒(野生型组,WT组)、21碱基缺失MEF2A质粒(A21突变组,A21组)和MEF2A siRNA片段(siRNA组)。应用细胞免疫荧光法检测MEF2A蛋白定位,MTT法测定内皮细胞增殖情况。结果绿色荧光蛋白结果与Flag抗体检测显示MEF2A基因成功转染,内皮细胞转染效率可达70%。与WT组比较,△21组MEF2A突变蛋白表达水平无显著变化,但其定位由核内转变为胞浆,siRNA组则使MEF2A蛋白表达下降80%。与WT组MEF2A转染相比,△21组和siRNA组脐静脉内皮细胞增殖率均显著下降(36.2%和63.6%,均为P〈0.01)。结论MEF2A基因可调节内皮细胞的增殖,其作用机制可能与MEF2A在细胞核内的定位相关。 Objective To investigate the effect of mutation of MEF2A on endothelial's proliferation. Methods Human umbilical vein endothelial cells (HUVECs) were transfected with one of the following plasmids: pcDNA-GFP plasmid (the control group), MEF2A wild-type plasmid (WT group), MEF2A 21-base pair deletion mutantion plasmid (△21 group), and MEF2A siRNA (siRNA group). Cell immunofluorescent assay was used to detect the location of the protein. HUVEC proliferation was analyzed by MTT. Results Transfection of MEF2A gene in HUVECs was detected by immunoblotting using anti-Flag antibody. The transfection efficiency of the HUVEC was approximately 70%. There was no significant difference in MEF2A protein expression between the wild-type and △21 mutation groups. SiRNA group has knockdown 80% of MEF2A protein expression compared with WT group. Immunofluorescence staining results showed that wild-type MEF2A protein was localized in the nucleus. The ATaa mutation of MEF2A protein in HUVECs could be detected in the cytoplasm. The proliferation of HUVEC was decreased in △21 (36. 2% , P 〈0. 01 ) and siRNA groups (63.6% , P 〈 0. 01 ) compared with that in the WT group. Conclusions Transfected MEF2A gene can regulate vascular endothelial cell proliferation. The shift of location of MEF2A protein may influence the process. The mechanism need to be further investigated.
出处 《中国心血管杂志》 2010年第3期223-226,共4页 Chinese Journal of Cardiovascular Medicine
基金 国家自然科学基金资助项目(30570755)
关键词 肌细胞 基因 内皮细胞 细胞增殖 Muscle cells Genes Endothelial cells Cell proliferation
  • 相关文献

参考文献14

  • 1Wang L,Fan C, Topol SE, et al. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science, 2003, 302: 1578-1581.
  • 2Naya FJ, Black BL, Wu H, et al. Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat Med, 2002, 8: 1303-1309.
  • 3Subramanian SV, Nadal-Ginard B. Early expression of the different isoforms of the myocyte enhancer factor-2 (MEF2) protein in myogenic as well as non-myogenic cell lineages during mouse embryogenesis. Mech Dev, 1996, 57: 103-112.
  • 4Hayashi M, Kim SW, Imanaka-Yoshida K, et al. Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J Clin Invest, 2004, 113: 1138- 1148.
  • 5Olson EN. Undermining the endothelium by ablation of MAPK- MEF2 signaling. J Clin Invest, 2004, 113 : 1110-1112.
  • 6Boulikas T. Putative nuclear localization signals (NLS) in protein transcription factors. J Cell Bioehem, 1994,55:32-58.
  • 7Kalderon D, Richardson WD, Markham AF, et al. Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature, 1984, 311: 33-38.
  • 8Yu YT. Distinct domains of myocyte enhancer binding factor-2A determining nuclear localization and cell type-specific transcriptional activity. J Biol Chem, 1996, 271 : 24675-24683.
  • 9Borghi S, Molinari S, Razzini G, et al. The nuclear localization domain of the MEF2 family of transcription factors shows member- specific features and mediates the nuclear import of histone deaeetylase 4. J Cell Sci, 2001, 114: 4477-4483.
  • 10Li A,Dubey S, Varney ML, et al. 1L-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol, 2003, 170: 3369-3376.

二级参考文献35

  • 1KatoY, Zhao M, Morikawa A, et al. Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. J Biol Chem ,2000,275 : 18534-18540.
  • 2Potthoff MJ, OIson EN. MEF2: a central regulator of diverse developmental programs. Developmen,2007 ,154 :4151-4140.
  • 3Wang L, Fan C,Topol SE, et al. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science,2003,302 : 1578-1581.
  • 4Bhagavatula MR, Fan C, Shen GQ, et al. Transcription factor MEF2A mutations in patients with coronary artery disease. Hum Mol Genet,2004,13:3181-3188.
  • 5Gonzalez P,Garcia-Castro M, Reguero JR, et al. The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction. J Med Genet,2006,43:167-169.
  • 6Weng L,Kavaslar N, Ustaszewska A, et al. Lack of MEF2A mutations in coronary artery disease. J Clin Invest,2005,115: 1016-1020.
  • 7Horan PG, Allen AR, Hughes AE, et al. Lack of MEF2A Deha7aa mutation in Irish families with early onset ischaemic heart disease, a family based study. BMC Med Genet,2006,7: 65.
  • 8Erdmann J, Mayer B, Fischer M, et al. Identification of rare forms of autosomal dominant heritability of myocardial infarction. Circulation ,2002,106:280-290.
  • 9Kajimoto K,Shioji K, Tago N, et al. Assessment of MERA mutations in myocardial infarction in Japanese patients. Circ J, 2005t ,69 : 1192-1195.
  • 10Gossett LA, Kelvin D J, Sternberg EA, et al. A new myocytespecific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol Cell Biol, 1989,9:5022-5033.

共引文献5

同被引文献6

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部